摘要:
The present invention provides a method and a device for color laser marking for attaining visible coloring without drastic modification of conventional devices and without using dyestuffs. To this end, in a color laser marking method, a workpiece (10) is a synthetic material made from organic and inorganic materials and, when irradiating laser light, patterns in different colors can be obtained by varying the received light intensity on the workpiece (10). In addition, in a color laser marking device, when the workpiece (10) is a synthetic material made from organic and inorganic materials, a controller (11) outputs laser irradiation intensity varying signals to at least one of laser irradiation intensity varying means, such as a laser oscillator (1).
摘要:
A ringtrip judging circuit includes a single comparator for comparing a detection value of a ringing current with a threshold value and for outputting the result of the comparison, a threshold value control circuit for supplying the threshold value to the comparator, and a judging circuit for judging ringtrip based on the output of the comparator. During a prescribed period after ringing signal transmission, the threshold value control circuit changes the threshold value in a steplike manner in accordance with the result of the comparison, thereby determining a threshold value greater than a peak value during the prescribed period, and based on it, determines a threshold value for ringtrip judgement and supplies it to the comparator.
摘要:
Peptide compounds of the formula (I') ##STR1## in which R.sup.1 is acyl,R.sup.2 is lower alkyl, cyclo(lower)alkyl(lower)alkyl or optionally substituted heterocyclic(lower)alkyl,R.sup.3 is optionally substituted heterocyclic(lower)alkyl or optionally substituted ar(lower)alkyl,R.sup.4 is lower alkyl, amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl or optionally substituted heterocyclic(lower)alkyl,R.sup.5 is carboxy, protected carboxy, carboxy(lower)alkyl or protected carboxy(lower)alkyl,R.sup.6 is hydrogen, lower alkyl, C.sub.6-10 ar(lower)alkyl amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, or heterocyclic(lower)alkyl,R.sup.7 is hydrogen or lower alkyl, andA is --O--, --NH--, lower alkylimino or lower alkylene, or a pharmaceutically acceptable salt thereof are disclosed. The compounds can be used to treat and prevent endothelin mediated diseases such as hypertension. The preparation of such peptides is also disclosed.
摘要:
This invention relates to pyrrolidine derivatives and pharmaceutically acceptable salts, their pharmaceutical compositions, and methods of use as thromboxane A.sub.2 antagonists and/or thromboxane A.sub.2 synthetase inhibitors in the treatment of thrombotic diseases, asthma or nephritis, e.g. of the formula: ##STR1## wherein R.sup.1 is thienyl(lower)alkyl, furyl(lower)alkyl or pyrrolyl(lower)alkyl.
摘要:
A developing device is provided with a developer vessel for storing therein a developer material composed of toner particles and carrier granules and a developer material supply section for gradually supplying a carrier developer including the carrier granules from above the developer vessel, wherein a discharge opening for discharging therethrough the developer material is formed on a side face of the developer vessel. When a tilt detection unit provided with the developing device detects the tilt of the developing device, an alarm lamp is set ON for sending a warning. In the meantime, the discharge opening is closed for preventing an excessive overflow of the developer material from the developer vessel.
摘要:
A compound of the formula: ##STR1## wherein R.sup.1 is carboxy or pharmaceutically acceptable salts and esters thereof;R.sup.2 is hydrogen, lower alkyl or halogen;R.sup.3 is phenyl, naphthyl, phenyl or naphthyl each substituted by from one to three C.sub.1-6 alkyl groups, mono-, di- or triphenyl (C.sub.1-6)alkyl; or substituted mono-, di- or triphenyl (C.sub.1-6) alkyl;A is lower alkylene which may be substituted by oxo or lower alkenylene,Q is carbonyl or lower alkylene,X is ##STR2## in which R.sup.4 is hydrogen or C.sub.1-6 alkyl, andR.sup.5 is hydrogen, C.sub.1-6 alkyl or Y--Z--R.sup.3,Y is a bond or lower alkylene,Z is lower alkylene ##STR3## in which R.sup.6 is hydrogen, (C.sub.1 -C.sub.6) alkyl, mono-, di- or triphenyl(C.sub.1-10) alkyl, C.sub.1-6 alkyl or lower alkoxycarbonyl substituted mono-, di- or triphenyl(C.sub.1-6)alkyl or pharmaceutically acceptable carboxylic acid acyl, and pharmaceutically acceptable salts thereof. The compound is useful as a testosterone 5.alpha.-reductase inhibitor.
摘要:
A compound of the formula: ##STR1## in which R.sup.1 and R.sup.2 are each hydrogen, halogen, nitro, amino, protected amino, hydroxyamino, lower alkyl, hydroxy, protected hydroxy, sulfamoyl, carboxy, protected carboxy, mercapto, optionally substituted heterocyclic-carbonyl, optionally substituted heterocyclic-(lower)alkyl, lower alkylthio, hydroxy(lower)alkyl or protected hydroxy(lower)alkyl,R.sup.3 is aryl which may have suitable substituent(s), andA is lower alkylene,or pharmaceutically acceptable salts thereof.
摘要:
Compounds of formula I, ##STR1## wherein R.sup.1 represents H, OH, protected OH or alkoxy; R.sup.2 represents H; R.sup.3 represents O or (H,OH); R.sup.4 represents methyl, ethyl, propyl or allyl; R.sup.5 represents OH, protected OH or alkoxy; R.sup.6 represents OH; R.sup.7 represents OH, alkoxy or NR.sup.8 R.sup.9 where R.sup.8 and R.sup.9 independently represent H, alkyl or aryl; in addition, R.sup.1 and R.sup.2 may together represent a second bond between the carbon atoms to which they are attached; and R.sup.6 and R.sup.7 may together represent O; and pharmaceutically acceptable salts thereof; are useful inter alia as immunosuppressive agents. The invention also provides the novel compounds of formula I.
摘要:
The invention relates to treatment of diseases caused by thromboxane A.sub.2 comprising administering a compound ##STR1## wherein R.sup.1 is hydrogen or lower alkyl,R.sup.2 is carboxy(lower)alkyl or protected carboxy(lower)alkyl andR.sup.3 is --CH.dbd.N--R.sup.4 in which R.sup.4 is arylureido or arylthioureido andX is --O--,or a pharmaceutically acceptable salt thereof.
摘要:
A catalyst composition for the vapor phase reduction of nitrogen oxides with ammonia, which consists essentially of a non-noble transition metal compound supported on a shaped carrier comprising a titanium oxide and a clay mineral having an average particle size of 0.1 to 100 microns. The shaped carrier preferably contains an additional component which is an inorganic fibrous material, silica hydrogel, silica sol, or a mixture of at least two of these. An exhaust gas containing nitrogen oxides is treated, with a high percent NO removal, by contacting it with the catalyst composition in the presence of ammonia gas at 200.degree. to 600.degree. C.